<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-9940</journal-id>
<journal-title><![CDATA[Archivos de cardiología de México]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Cardiol. Méx.]]></abbrev-journal-title>
<issn>1405-9940</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Cardiología Ignacio Chávez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-99402014000100013</article-id>
<article-id pub-id-type="doi">10.1016/j.acmx.2013.11.002</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Substrate-based strategies for paroxysmal refractory VT catheter ablation: Coming of age?]]></article-title>
<article-title xml:lang="es"><![CDATA[Técnicas basadas en el sustrato para la ablación con catéter de la TV paroxística refractaria: ¿están lo suficientemente maduras?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nitu]]></surname>
<given-names><![CDATA[Dorian]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Waintraub]]></surname>
<given-names><![CDATA[Xavier]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tonet]]></surname>
<given-names><![CDATA[Joelci]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Pitié-Salpêtrière Hospital Rhythmology Unit Cardiology Institute]]></institution>
<addr-line><![CDATA[Paris ]]></addr-line>
<country>France</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2014</year>
</pub-date>
<volume>84</volume>
<numero>1</numero>
<fpage>55</fpage>
<lpage>56</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-99402014000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-99402014000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-99402014000100013&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[ <p align="justify"><font face="verdana" size="4">Cartas al editor</font></p>     <p align="center">&nbsp;</p>     <p align="center"><font face="verdana" size="4"><b>Substrate&#45;based strategies for paroxysmal refractory VT catheter ablation: Coming of age?</b></font></p>     <p align="center"><font face="verdana" size="2">&nbsp;</font></p>     <p align="center"><font face="verdana" size="3"><b>T&eacute;cnicas basadas en el sustrato para la ablaci&oacute;n con cat&eacute;ter de la TV parox&iacute;stica refractaria: &iquest;est&aacute;n lo suficientemente maduras?</b></font></p>     <p align="center"><font face="verdana" size="2">&nbsp;</font></p>     <p align="center"><font face="verdana" size="2"><b>Dorian Nitu, Xavier Waintraub, Joelci Tonet *</b></font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><i>Cardiology Institute, Rhythmology Unit, Piti&eacute;&#45;Salp&ecirc;tri&egrave;re Hospital, Paris, France</i></font></p>     <p align="justify"><font face="verdana" size="2">* Corresponding author. <i>E&#45;mail address:</i> <a href="mailto:joelci.tonet@psl.aphp.fr">joelci.tonet@psl.aphp.fr</a> (J. Tonet). </font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><i>Dear Editor,</i></font></p>     <p align="justify"><font face="verdana" size="2">Patients with ischemic and nonischemic cardiomyopathy are at increased risk of sudden death due to ventricular arrhythmias. Implantable cardioverter&#45;defibrillators (ICD) have lowered this mortality rate; however, ICD shocks impact quality of life.<sup>1</sup> Medical treatment with the combination of betablockers with amiodarone reduces ventricular tachycardia (VT) inducibility<sup>2</sup> and ICD shocks,<sup>3</sup> but long&#45;term side effects are unfortunately relatively frequent. In patients with sustained paroxysmal refractory VT, catheter ablation has been proven to reduce VT recurrence by directly addressing the arrhythmogenic substrate, albeit at a procedure&#45;dependent risk; nevertheless, ablation has no effect on mortality.<sup>4</sup></font></p>     <p align="justify"><font face="verdana" size="2">Catheter mapping of recurrent VT relies on arrhythmia induction and identification of ablation targets (isthmuses and exit sites) by entrainment and activation criteria during ongoing VT. Ideally, it provides an endpoint to the procedure in the case of non&#45;inducibility of VT. However, this approach is somewhat difficult due to some potential limitations: non&#45;inducibility of VT, VT pleomorphism due to complex substrates, hemodynamic compromise. Therefore, these limitations have driven the development of substrate&#45;based mapping and new ablation strategies.</font></p>     <p align="justify"><font face="verdana" size="2">In patients with structural heart disease, ventricular scar represents the anatomical (and electrophysiological) basis for VT initiation and its maintenance. Abnormal local electrograms in sinus rhythm (SR) have been identified in border zones surrounding the scar. Surgical resection of subendocardial and/or epicardial reentry circuits was first attempted as an ablative method.</font></p>     <p align="justify"><font face="verdana" size="2">In the February 2013 issue of this Journal, Vergara et al. published a review of current substrate&#45;based strategies for VT catheter ablation.<sup>5</sup> They comprehensively describe several approaches to substrate ablation. The first two methods reported, conceptually derived from surgical ablation, employ linear ablation lines to cross, encircle or link the scar and anatomical barriers. Arenal et al.<sup>6</sup> elegantly identified channels of delayed conduction through the scar zone through a step&#45;wise reduction in voltage thresholds, targeting these areas with relatively few applications. However, the absence of a clear end point can limit its efficacy. The same technique was used by Berruezo et al.<sup>7</sup> in a series of arrhythmogenic right ventricular dysplasia patients. Alternatively, Vergara et al.<sup>8</sup> focused on complete mapping and ablation of late potentials (LPs), combined with pace&#45;mapping in SR and, when possible, entrainment maneuvers. LPs ablation was associated with low VT recurrence rates and was a good predictor of arrhythmia&#45;free survival. Thus, the authors postulated that &quot;complete&quot; LPs elimination is superior to non&#45;inducibility of VT, given its ability to simultaneously address multiple circuits.</font></p>     <p align="justify"><font face="verdana" size="2">In spite of their promising results, several limitations remain. The population of these studies is heterogeneous as to VT induction and hemodynamic stability, thereby providing a possible bias. While the procedural endpoint has mostly been substrate&#45;based, Soejima et al.<sup>9</sup> found that non&#45;identification of an isthmus was associated with recurrence. Also, different bipolar voltage cut&#45;offs were used. Lastly, the ablation strategies have not been directly compared.</font></p>     <p align="justify"><font face="verdana" size="2">Despite these limitations, the current review by Vergara et al. suggests that substrate mapping and ablation strategies could be a valuable addition to the field of chronic recurrent VT catheter ablation, hopefully translating into a better clinical benefit for our patients.</font></p>     <p align="justify"><font face="verdana" size="2">&nbsp;</font></p>     <p align="justify"><font face="verdana" size="2"><b>References</b></font></p>     ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">1.&nbsp;Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009&#45;17.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127676&pid=S1405-9940201400010001300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">2.&nbsp;Tonet J, Frank R, Fontaine G, Grosgogeat Y. Efficacy and safety of low doses of beta&#45;blocker agents combined with amiodarone in refractory ventricular tachycardia. PACE. 1988;11:1984&#45;9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127678&pid=S1405-9940201400010001300002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">3.&nbsp;Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta&#45;blockers, amiodarone plus beta&#45;blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295:165&#45;71.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127680&pid=S1405-9940201400010001300003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">4.&nbsp;Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta&#45;analysis of catheter ablation as an adjunct to medical therapyfor treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm. 2011;8:503&#45;10.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127682&pid=S1405-9940201400010001300004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">5.&nbsp;Vergara P, Roque C, Oloriz T, Mazzone P, Delia Bella P. Substrate mapping strategies for successful ablation of ventricular tachycardia: a review. Arch Cardiol Mex. 2013;83: 104&#45;11.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127684&pid=S1405-9940201400010001300005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">6.&nbsp;Arenal A, del Castillo S, Gonzalez&#45;Torrecilla E, Atienza F, Ortiz M, Jimenez J, et al. Tachycardia&#45;related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias: influence of the voltage scar definition. Circulation. 2004;10:2568&#45;74.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127686&pid=S1405-9940201400010001300006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">7.&nbsp;Berruezo A, Fern&acirc;ndez&#45;Armenta J, Mont L, Zeljko H, Andreu D, Herczku C, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012;5:111&#45;21.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127688&pid=S1405-9940201400010001300007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">8.&nbsp;Vergara P, Trevisi N, Ricco A, Petracca F, Baratto F, Cireddu M, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2012;23:621&#45;7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127690&pid=S1405-9940201400010001300008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>     <!-- ref --><p align="justify"><font face="verdana" size="2">9. Soejima K, Suzuki M, Maisel WH, Brunckhorst CB, Delacretaz E, Blier L, et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation. 2001;104:664&#45;9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1127692&pid=S1405-9940201400010001300009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poole]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Hellkamp]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Callans]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Raitt]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prognostic importance of defibrillator shocks in patients with heart failure]]></article-title>
<source><![CDATA[N Engl J Med.]]></source>
<year>2008</year>
<volume>359</volume>
<page-range>1009-17</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tonet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Frank]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fontaine]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Grosgogeat]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia]]></article-title>
<source><![CDATA[PACE]]></source>
<year>1988</year>
<volume>11</volume>
<page-range>1984-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connolly]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dorian]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Gent]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bailin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fain]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2006</year>
<volume>295</volume>
<page-range>165-71</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mallidi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nadkarni]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Calkins]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nazarian]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Meta-analysis of catheter ablation as an adjunct to medical therapyfor treatment of ventricular tachycardia in patients with structural heart disease]]></article-title>
<source><![CDATA[Heart Rhythm.]]></source>
<year>2011</year>
<volume>8</volume>
<page-range>503-10</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vergara]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Roque]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Oloriz]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mazzone]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Delia Bella]]></surname>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Substrate mapping strategies for successful ablation of ventricular tachycardia: a review]]></article-title>
<source><![CDATA[Arch Cardiol Mex.]]></source>
<year>2013</year>
<volume>83</volume>
<page-range>104-11</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arenal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[del Castillo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez-Torrecilla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Atienza]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jimenez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tachycardia-related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias: influence of the voltage scar definition.]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2004</year>
<volume>10</volume>
<page-range>2568-74</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berruezo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernândez-Armenta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mont]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zeljko]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Andreu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Herczku]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique]]></article-title>
<source><![CDATA[Circ Arrhythm Electrophysiol.]]></source>
<year>2012</year>
<volume>5</volume>
<page-range>111-21</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vergara]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Trevisi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ricco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Petracca]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Baratto]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cireddu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation]]></article-title>
<source><![CDATA[J Cardiovasc Electrophysiol.]]></source>
<year>2012</year>
<volume>23</volume>
<page-range>621-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soejima]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Suzuki]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Maisel]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Brunckhorst]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Delacretaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Blier]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2001</year>
<volume>104</volume>
<page-range>664-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
